Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.
Clinical trial NCT04774926 · COMPLETED
Trial details
- NCT number
- NCT04774926
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2023-10-04
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.